Skip to main content



Local Cdiff information for South Carolina

South Carolina

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in South Carolina.



Local Cdiff information for South Carolina

South Carolina

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in South Carolina.

Providers

Scott Curry, MD

MUSC Health Ashley River Tower
25 Courtenay Dr
Charleston, SC 29425

(843) 792-2300

VISIT WEBSITE>

Emilio V. Perez-Jorge, MD, FACP

Lexington Medical Park 2
146 East Hospital Drive
Suite 120A
West Columbia, SC 29169

Phone: (803) 936-7460

VISIT WEBSITE>>>

Regulation

C. diff Infections

Total Reported Cases: 1255
Hospital Onset: 1255
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.75
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: Yes
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: Yes
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: South Carolina Law
STATUTE >

State Contact

Kate Habicht, MPH
Healthcare-associated Infections Epidemiologist
South Carolina Department of Health and Environmental Control
Division of Acute Disease Epidemiology
2100 Bull St.
Columbia, 29201
(803) 898-0575
(803) 898-0897
EMAIL KATE HABICHT, MPH >

CLINICAL TRIALS

ROAR

Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact: Global Clinical Compliance
833-548-1402
EMAIL
Gender: All
Age: 18 Years and older

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older

C.Difficile Observational Study

Official Title: An Observational Study in Adults With Clostridioides Difficile Infection to Determine the Feasibility and Logistics of Biospecimen Collection, Transportation and Testing at Select US Study Sites
Trial No. NCT06277999
Type: Observational
Recruitment: Recruiting
Sponsor: AstraZeneca
Contact: AstraZeneca Clinical Study Information Center
EMAIL >
Gender: All
Age: 18 Years and older